FDA News Releases Jun 12, 2026 FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children
FDA News Releases Jun 11, 2026 FDA Issues Emergency Use Authorization for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats
FDA News Releases Jun 2, 2026 FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
FDA News Releases May 29, 2026 FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
FDA News Releases May 22, 2026 FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
FDA News Releases May 20, 2026 FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products
FDA News Releases May 12, 2026 FDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADA
FDA News Releases May 8, 2026 FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
FDA News Releases May 8, 2026 FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
FDA News Releases May 6, 2026 FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
FDA News Releases Apr 30, 2026 FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia
FDA News Releases Apr 30, 2026 FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List
FDA News Releases Apr 29, 2026 FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.